David Goldstein, CEO of PotBotics, a start-up developing EEG brain scan technology that would allow doctors to recommend specific strains of medical marijuana based on the results of a scan.

I would argue that it absolutely has already made an impact on society, and a positive one at that. Without clear FDA testing, patients are required to educate themselves about cannabis and its effects. At PotBotics, we have created a turnkey solution for patients to educate themselves about cannabis and what studies have been done for their specific ailments and needs. This has created more confident patients that can access the industry with a higher transparency than was previously available.